![]() |
市場調査レポート
商品コード
1626553
脱毛治療製品市場:製品タイプ別、流通チャネル別、地域別、2024年~2031年Hair Loss Treatment Products Market By Product Type (Shampoo & Conditioner, Oil, Serum), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Specialty Retailers, Pharmacies, Online Retail), & Region for 2024-2031 |
||||||
|
脱毛治療製品市場:製品タイプ別、流通チャネル別、地域別、2024年~2031年 |
出版日: 2024年10月31日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
ストレスの増加、食生活の乱れ、ホルモンバランスの乱れ、男性型脱毛症の増加などが市場の成長に寄与しています。消費者の身だしなみや美意識が高まっています。若々しさを重視する傾向が強まり、男女ともに薄毛やハゲの効果的な対策方法を探すようになり、2024年には234億米ドル、2031年には634億米ドルに達する勢いです。
レーザー治療や育毛美容液などの技術改良と、市販品の入手可能性の増加が、市場拡大の原動力となっています。さらに、ソーシャルメディアや有名人によるヘアケア製品の推奨が消費者の関心を高め、脱毛治療は世界的に盛況な分野へと変貌を遂げ、2024年から2031年までのCAGRは約13.26%で成長しています。
脱毛治療製品市場:定義/概要
抜け毛治療製品には、薄毛やハゲを遅らせたり、予防したり、回復させたりすることを目的とした薬剤、外用治療薬、シャンプー、美容液、ガジェットなどが含まれます。これらの製品はしばしば、男性型脱毛症、ホルモン性脱毛、環境による毛髪損傷の治療に使用されます。発毛を促進し、既存の毛髪を強化し、さらなる脱毛を防ぐといった用途があり、男女ともに人気があります。バイオテクノロジーの進歩、個別化治療、非侵襲的治療に対する顧客ニーズの高まりにより、同市場の将来性は高いです。幹細胞治療や発毛促進処方などの革新的技術が、今後の市場成長を促進すると予測されます。
薄毛治療市場の世界のレーザー治療分野は急速に拡大しており、レーザーを用いたソリューションが非侵襲的な治療オプションとして人気を集めています。2024年2月のMarket Watchデータによると、レーザー治療市場は2023年に31億米ドルを生み出し、2028年まで15.6%のCAGRで上昇すると予想されています。2024年1月、FDAはアップグレードされた家庭用レーザー治療器を承認し、消費者の受容率は92%上昇しました。2024年3月「International Journal of Trichology」に掲載された最近の臨床試験で、低レベルレーザー治療(LLLT)が6ヵ月間にわたって85%の参加者の毛髪再生に成功し、特に25~45歳の患者に有効であることが明らかになりました。
Philipsは2023年12月に、AIを搭載した画期的なレーザー治療用帽子を発売する予定であり、臨床テストでは毛髪密度が67%改善したことが示されています。レーザー機器の世界的リーダーであるHairMaxは、2024年2月、1億5,000万米ドルの投資を背景に、中国のヘルスケア企業BeiGeneと戦略的提携を結び、アジア全域に最新のレーザーバンド技術を提供すると発表しました。2024年3月、欧州医薬品庁(EMA)はレーザー治療と成長因子を組み合わせた新しい併用療法を承認し、2024年4月、オーストラリア政府は毛髪再生のための強化レーザー技術の調査のために7,500万豪ドルを確保しました。さらに、Venus Conceptが2024年3月に発表した四半期報告書では、レーザー機器の売上高が前年比178%増となり、消費者の拡大を示しています。
製品コストの高さと性能のばらつきは、脱毛治療製品市場の拡大を著しく阻害する可能性があります。特に処方箋が必要な治療や、幹細胞治療のような高度な治療を伴う治療の多くは高額です。このため、特に可処分所得が少ない新興国では、より多くの消費者層へのアクセスが制限される可能性があります。さらに、継続的な治療に伴う経済的負担は、顧客が完全に治療法を追求することを妨げ、結果として市場の需要を低下させる可能性があります。例えば、一部の消費者は、成功した薄毛治療法にはお金を払う用意があるかもしれませんが、結果が不確実なため、特に以前効果の低い商品で失望したことのある消費者は、出費に慎重になるかもしれません。
さらに、薄毛治療薬の効能にばらつきがあることが、消費者の不信感や不満につながるかもしれません。ミノキシジルやフィナステリドのような外用療法を含め、市場に出回っている多くの医薬品は、すべての人に結果が保証されるとは限らず、その結果、さまざまな使用経験がもたらされます。あらゆるタイプの脱毛に対応する共通の治療薬がないため、遺伝的、ホルモン的、生活習慣的な変数によって個々の治療効果が異なる可能性があり、問題はさらに複雑になります。この食い違いは市場の信頼を失い、潜在的な顧客は別の治療法を探したり、治療を完全に避けざるを得なくなる可能性があります。その結果、生産者は良い製品を製造するだけでなく、消費者の間で評判と信頼を築くという問題に直面することになります。
Increasing stress, poor diet, hormonal imbalances, and an increase in occurrences of androgenetic alopecia are all contributing to the market's growth. Consumers are becoming more conscious of their personal grooming and aesthetics. With a greater emphasis on young appearance, both men and women are looking for effective ways to counteract hair thinning and balding is fuelling the USD 23.4 Billion in 2024 and reaching USD 63.4 Billion by 2031.
Technological improvements such as laser therapy and hair growth serums, together with increased availability of over-the-counter products, are driving market expansion. Furthermore, the influence of social media and celebrity endorsements of hair care products has raised consumer interest, transforming hair loss therapy into a thriving sector globally is grow at a CAGR of about 13.26% from 2024 to 2031.
Hair Loss Treatment Products Market: Definition/ Overview
Hair loss therapy goods include drugs, topical treatments, shampoos, serums, and gadgets that aim to delay, prevent, or reverse hair thinning and balding. These products are often used to treat androgenetic alopecia, hormonal hair loss, and environmental hair damage. Applications include increasing hair regrowth, strengthening existing hair, and preventing further hair loss, and are popular with both men and women. This market's future looks good, owing to advances in biotechnology, individualized treatments, and rising customer demand for non-invasive remedies. Innovations such as stem cell therapy and enhanced hair growth formulas are projected to fuel future market growth.
The global laser therapy segment of the hair loss treatment market is rapidly expanding, with laser-based solutions emerging as a popular non-invasive treatment option. According to Market Watch data from February 2024, the laser therapy market generated USD 3.1 Billion in 2023 and is expected to rise at a CAGR of 15.6% through 2028. In January 2024, the FDA approved upgraded at-home laser therapy equipment, which resulted in a 92% rise in consumer acceptance rates. In March 2024 Recent clinical trials published in the International Journal of Trichology found that low-level laser therapy (LLLT) resulted in successful hair regeneration in 85% of participants over a six-month period, with particular efficacy among patients aged 25-45.
Philips will released their groundbreaking AI-powered laser therapy hat in December 2023, with clinical testing showing a 67% improvement in hair density. HairMax, a world leader in laser devices, announced in February 2024 a strategic alliance with Chinese healthcare company BeiGene to deliver its latest laser band technology throughout Asia, backed by a USD 150 Million investment. In March 2024, the European Medicines Agency (EMA) approved a new combination therapy combining laser treatment with growth factors, while in April 2024 the Australian government set aside AUD 75 million for research into enhanced laser technology for hair restoration. Furthermore, Venus Concept's quarterly report in March 2024 disclosed a 178% rise in laser device sales compared to the previous year, demonstrating the expanding consumer
High product costs and uneven performance can seriously impede the expansion of the hair loss treatment products market. Many treatments, particularly those requiring a prescription or involving advanced therapies such as stem cell treatments, are expensive. This can limit access to a larger consumer base, especially in emerging economies with smaller disposable expenditures. Furthermore, the financial burden involved with continued therapies may prevent customers from pursuing remedies entirely, resulting in lower market demand. For example, while some consumers may be prepared to pay in successful hair loss solutions, uncertainty about the results may lead to caution in spending, especially for those who have previously encountered disappointment with less effective items.
Furthermore, the uneven efficacy of hair loss therapies might lead to consumer distrust and unhappiness. Many medicines on the market, including topical therapies like as minoxidil and finasteride, may not guarantee results for everyone, resulting in diverse user experiences. The lack of a common remedy for all types of hair loss complicates matters further, as individual therapy responses can vary depending on genetic, hormonal, and lifestyle variables. This discrepancy may lead to a loss of trust in the market, forcing potential clients to seek alternate cures or avoid therapy entirely. As a result, producers confront the problem of not only manufacturing good products but also building reputation and confidence among consumers.
Shampoos and conditioners are widely used in regular hair care routines, which might greatly boost the market for hair loss treatment solutions. As people become more aware of the importance of scalp health and hair maintenance, they are incorporating specialist hair care products that address hair loss into their regular routines. For example, manufacturers like as Nioxin and Kerastase are introducing shampoos and conditioners that are particularly designed to strengthen hair and stimulate growth while also addressing thinning hair concerns. In May 2024 L'Oreal launched plant-based hair care products to improve scalp health and meet the growing demand for eco-friendly choices. This emphasis on preventive care is causing more people to seek items that not only clean and condition hair but also contribute to overall hair health.
In April 2024, the FDA announced its support for clinical research on new formulations that combine traditional hair care products with active hair restoration chemicals, with the goal of increasing their effectiveness. This regulatory backing is anticipated to increase consumer trust in using these products on a regular basis, as they are intended not only for cosmetic appeal but also for genuine hair growth benefits.
However, the serum segment is the fastest expanding, owing to increased demand for focused therapies with greater efficacy and faster outcomes. Hair growth serums, which are frequently loaded with modern compounds such as peptides and minoxidil, are gaining popularity among consumers looking for more effective, non-invasive treatments for hair thinning and regrowth.
Rising sales through pharmacies are expected to greatly boost the hair loss treatment products industry. Pharmacies are increasingly becoming favored distribution channels for hair loss treatments due to their accessibility and consumers' trust in them for health-care items. The simplicity of purchasing hair loss remedies alongside other personal care items appeals to consumers looking for discreet and uncomplicated answers to their hair problems. Recent agreements between pharmaceutical firms and retail chains aim to increase the availability of popular therapies such as minoxidil and finasteride, allowing consumers to obtain effective remedies more easily. For instance, in June 2024, Walgreens announced a collaboration with numerous producers to ensure that popular hair loss remedies are more prominently advertised in their shops, thus catering to rising consumer demand.
In February 2024, the United States Department of Health initiated a campaign to educate the public on hair health, including the availability of treatments at local pharmacies. This campaign is aimed to raise awareness and encourage customers to seek out drugstore remedies for hair loss. With pharmacies serving as trustworthy sources of health information, this effort attempts to increase consumer confidence in purchasing hair loss remedies.
However, the fastest expanding area is online retail, which is driven by the convenience of home delivery, a larger selection of product offerings, and rising consumer preference for e-commerce platforms. Discounts, user reviews, and focused marketing all help online shops by attracting tech-savvy consumers looking for individualized hair loss solutions.
Country/Region-wise
The North American hair loss treatment products market is expanding rapidly, driven by rising demand for aesthetic treatments and increased awareness of innovative hair restoration options. According to latest market research data from March 2024, the market value hit USD 4.2 Billion in 2023 and is expected to increase at a CAGR of 9.8% between 2024 and 2028. This increase is most obvious in the United States, where roughly 50 million men and 30 million women suffer from hair loss, with 66% of males experiencing visible hair loss by the age of 35, according to the American Hair Loss Association's January 2024 report.
In August 2023, Johnson & Johnson's announced of their improved topical hair growth solution, which had an 85% success rate in clinical trials, and Merck received FDA clearance in February 2024 for a novel oral therapy for androgenetic alopecia. Additionally, in September 2023, the Canadian government announced a USD 50 Million investment in research funding for hair restoration technologies, with an emphasis on stem cell therapy and individualized treatment options. The advent of telemedicine services has also aided market growth, with companies such as Hims & Hers reporting a 120% increase in hair loss consultations in Q4 2023 over the previous year.
The Asia Pacific hair loss treatment products market is experiencing unprecedented expansion, driven by rising beauty consciousness and rising disposable income across the region. According to a Verified Market Research published the hair care market is predicted to rise at a CAGR of 5.60% to USD 129.63 Billion by 2031, from USD 83.83 Billion in 2023. China leads this expansion, accounting for 34% of the market, followed by Japan and South Korea. According to the Asian Dermatological Association's March 2024 report, 42% of men and 25% of women in metropolitan Asian areas suffer from premature hair loss, with a 73% increase in treatment-seeking behavior among people aged 25-40 over the last two years.
In February 2024, the Japanese government announced a historic USD 200 Million effort to promote research and development in hair restoration technology, while Singapore's Health Sciences Authority (HSA) gave fast-track approval status to three innovative hair loss therapies in March 2024. Alibaba, the Chinese e-commerce giant, reported that hair loss treatment product sales increased by 156% year on year during the 2024 Lunar New Year shopping festival, while Indian pharmaceutical company Sun Pharma announced in April 2024 that it would expand its hair care portfolio by acquiring a Korean hair technology startup for USD 180 Million.
The competitive landscape of the Hair Loss Treatment Products Market is characterized by the presence of various players offering a range of solutions, including prescription medications, over-the-counter treatments, and natural or herbal remedies. The market is increasingly driven by innovation, with companies focusing on developing new, advanced formulations like low-level laser therapy (LLLT) devices and stem cell treatments. Consumer preference for non-invasive and natural solutions is also shaping the market. Additionally, the rise of e-commerce platforms has intensified competition, as brands target a global audience through online sales channels, offering customized treatment plans and subscription-based services.
Some of the prominent players operating in the hair loss treatment products market Include:
L'Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang
In July 2024, L'Oreal has launched a new plant-based, eco-friendly hair serum as part of its sustainability effort. The serum, which is part of the Kerastase line, targets early-stage hair thinning and is likely to appeal to environmentally aware consumers.
In June 2024, RepliCel announced development in its dermal sheath cup cell treatment for hair restoration. Early clinical data suggest enhanced hair follicle regeneration, and expanded trials are scheduled for late 2024.
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang